KEY TEACHING POINTS

•Craniofacial pain and syncope are associated with glossopharyngeal neuralgia (GN). •Carbamazepine is considered a first-line treatment of GN. •Bradyarrhythmic complications of GN are treated with anticholinergic medications or with a β2-adrenoreceptor agonist. •The need for demand dual-chamber pacemakers in the long-term treatment of GN remains controversial.